Dudley, Matthew Z. http://orcid.org/0000-0003-1201-4066
Schuh, Holly B. http://orcid.org/0000-0002-7901-4477
Forr, Amanda
Shaw, Jana
Salmon, Daniel A.
Funding for this research was provided by:
Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC
Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC
Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC
Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC
Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC
Article History
Received: 2 October 2023
Accepted: 1 February 2024
First Online: 28 February 2024
Competing interests
: Matthew Dudley has received research support from Merck. Daniel Salmon has received research support from Merck and serves on advisory boards for Merck, Janssen, Sanofi, and Moderna. Matthew Dudley and Daniel Salmon have received funding from the Vaccination Confidence Fund, which is jointly funded by Facebook and Merck. Holly Schuh served as a (paid) health advisor to the University of Roehampton that provided guidance on recovery-building and future pandemic preparedness (including views on vaccines/vaccination) and understanding citizen engagement in the G7 in 2021-22 (during the presented study). Jana Shaw serves as a consultant to Pfizer on meningococcal B vaccine. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.